Safrazine (Safra) is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was used introduced as an antidepressant in the 1960s and is still used in Japan today. As with all MAOIs safrazine is contraindicated in patients using SSRIs SSRAs and serotonin agonists.
This page contains content from the copyrighted Wikipedia article "Safrazine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
